- call +1-201-465-4211
- email sales@mrinsights.biz
The global biopharmaceutical industry is the most rapidly growing industry in the science and technology sector owing to increasing R&D investments in biopharmaceutical drug development facilities. The global automation market in biopharmaceutical industry includes deployment of automation in biopharmaceutical academic research centers, manufacturing and research companies, clinical labs, and government approved labs.
Scope of the Report:
This report focuses on the Automation in Biopharmaceutical Industry in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
One trend in the market is continuous manufacturing. Advantages of continuous operations are well-recognized in various industries. It completes the process in a shorter time as it omits the hold steps, reduces shut down time, and reduces the labor requirement. Over the decades, upstream processing utilized this technology.”
According to the report, one driver in the market is use of automation in data acquisition. Traditionally, research labs collect data manually and store it in spreadsheets. This method is not only time-consuming but also affects operational efficiency and is prone to errors. It also restricts monitoring of data in real time. The biopharmaceutical industry is working on data collection and adding the information from spreadsheets to a database. Database collection of upstream and downstream processes is being utilized to create a library that increases operational efficiency and process optimization.
Further, the report states that one challenge in the market is high R&D cost. The biopharmaceutical industry is a rapidly growing industry in pharmaceuticals. Complex drugs are manufactured with the help of 3-D modeling and are produced with high efficacy and precision. These drugs can provide medication to medical issues that were once incurable. Currently, the biopharmaceutical industry is looking to yield new products to address diseases such as cancer, Alzheimer's disease, and hepatitis C. Innovations in the biopharmaceutical industry are highly expensive. The average cost associated with a new drug is around $2 billion, including the cost of unsuccessful drug approvals, out of which almost $400 million is the cost included in pre-clinical and clinical testing.
The worldwide market for Automation in Biopharmaceutical Industry is expected to grow at a CAGR of roughly 6.2% over the next five years, will reach 1410 million US$ in 2023, from 1040 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Danaher
GE
PerkinElmer
Tecan Trading
Thermo Fisher Scientific
Bruker
Peak Analysis & Automation
Waters
Capsugel
RheoSense
Eirechrom
BioProcess International
Novasep
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Clinical stage automation
Drug discovery stage automation
Market Segment by Applications, can be divided into
Research and Development
Clinical
There are 15 Chapters to deeply display the global Automation in Biopharmaceutical Industry market.
Chapter 1, to describe Automation in Biopharmaceutical Industry Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Automation in Biopharmaceutical Industry, with sales, revenue, and price of Automation in Biopharmaceutical Industry, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Automation in Biopharmaceutical Industry, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Automation in Biopharmaceutical Industry market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Automation in Biopharmaceutical Industry sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Automation in Biopharmaceutical Industry Introduction
1.2 Market Analysis by Type
1.2.1 Clinical stage automation
1.2.2 Drug discovery stage automation
1.3 Market Analysis by Applications
1.3.1 Research and Development
1.3.2 Clinical
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Danaher
2.1.1 Business Overview
2.1.2 Automation in Biopharmaceutical Industry Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Danaher Automation in Biopharmaceutical Industry Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 GE
2.2.1 Business Overview
2.2.2 Automation in Biopharmaceutical Industry Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GE Automation in Biopharmaceutical Industry Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 PerkinElmer
2.3.1 Business Overview
2.3.2 Automation in Biopharmaceutical Industry Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 PerkinElmer Automation in Biopharmaceutical Industry Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Tecan Trading
2.4.1 Business Overview
2.4.2 Automation in Biopharmaceutical Industry Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Tecan Trading Automation in Biopharmaceutical Industry Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Thermo Fisher Scientific
2.5.1 Business Overview
2.5.2 Automation in Biopharmaceutical Industry Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Thermo Fisher Scientific Automation in Biopharmaceutical Industry Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bruker
2.6.1 Business Overview
2.6.2 Automation in Biopharmaceutical Industry Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bruker Automation in Biopharmaceutical Industry Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Peak Analysis & Automation
2.7.1 Business Overview
2.7.2 Automation in Biopharmaceutical Industry Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Peak Analysis & Automation Automation in Biopharmaceutical Industry Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Waters
2.8.1 Business Overview
2.8.2 Automation in Biopharmaceutical Industry Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Waters Automation in Biopharmaceutical Industry Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Capsugel
2.9.1 Business Overview
2.9.2 Automation in Biopharmaceutical Industry Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Capsugel Automation in Biopharmaceutical Industry Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 RheoSense
2.10.1 Business Overview
2.10.2 Automation in Biopharmaceutical Industry Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 RheoSense Automation in Biopharmaceutical Industry Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Eirechrom
2.11.1 Business Overview
2.11.2 Automation in Biopharmaceutical Industry Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Eirechrom Automation in Biopharmaceutical Industry Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 BioProcess International
2.12.1 Business Overview
2.12.2 Automation in Biopharmaceutical Industry Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 BioProcess International Automation in Biopharmaceutical Industry Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Novasep
2.13.1 Business Overview
2.13.2 Automation in Biopharmaceutical Industry Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Novasep Automation in Biopharmaceutical Industry Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Automation in Biopharmaceutical Industry Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Automation in Biopharmaceutical Industry Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Automation in Biopharmaceutical Industry Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Automation in Biopharmaceutical Industry Manufacturer Market Share in 2017
3.3.2 Top 6 Automation in Biopharmaceutical Industry Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Automation in Biopharmaceutical Industry Market Analysis by Regions
4.1 Global Automation in Biopharmaceutical Industry Sales, Revenue and Market Share by Regions
4.1.1 Global Automation in Biopharmaceutical Industry Sales and Market Share by Regions (2013-2018)
4.1.2 Global Automation in Biopharmaceutical Industry Revenue and Market Share by Regions (2013-2018)
4.2 North America Automation in Biopharmaceutical Industry Sales and Growth Rate (2013-2018)
4.3 Europe Automation in Biopharmaceutical Industry Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Automation in Biopharmaceutical Industry Sales and Growth Rate (2013-2018)
4.5 South America Automation in Biopharmaceutical Industry Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Automation in Biopharmaceutical Industry Sales and Growth Rate (2013-2018)
5 North America Automation in Biopharmaceutical Industry by Countries
5.1 North America Automation in Biopharmaceutical Industry Sales, Revenue and Market Share by Countries
5.1.1 North America Automation in Biopharmaceutical Industry Sales and Market Share by Countries (2013-2018)
5.1.2 North America Automation in Biopharmaceutical Industry Revenue and Market Share by Countries (2013-2018)
5.2 United States Automation in Biopharmaceutical Industry Sales and Growth Rate (2013-2018)
5.3 Canada Automation in Biopharmaceutical Industry Sales and Growth Rate (2013-2018)
5.4 Mexico Automation in Biopharmaceutical Industry Sales and Growth Rate (2013-2018)
6 Europe Automation in Biopharmaceutical Industry by Countries
6.1 Europe Automation in Biopharmaceutical Industry Sales, Revenue and Market Share by Countries
6.1.1 Europe Automation in Biopharmaceutical Industry Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Automation in Biopharmaceutical Industry Revenue and Market Share by Countries (2013-2018)
6.2 Germany Automation in Biopharmaceutical Industry Sales and Growth Rate (2013-2018)
6.3 UK Automation in Biopharmaceutical Industry Sales and Growth Rate (2013-2018)
6.4 France Automation in Biopharmaceutical Industry Sales and Growth Rate (2013-2018)
6.5 Russia Automation in Biopharmaceutical Industry Sales and Growth Rate (2013-2018)
6.6 Italy Automation in Biopharmaceutical Industry Sales and Growth Rate (2013-2018)
7 Asia-Pacific Automation in Biopharmaceutical Industry by Countries
7.1 Asia-Pacific Automation in Biopharmaceutical Industry Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Automation in Biopharmaceutical Industry Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Automation in Biopharmaceutical Industry Revenue and Market Share by Countries (2013-2018)
7.2 China Automation in Biopharmaceutical Industry Sales and Growth Rate (2013-2018)
7.3 Japan Automation in Biopharmaceutical Industry Sales and Growth Rate (2013-2018)
7.4 Korea Automation in Biopharmaceutical Industry Sales and Growth Rate (2013-2018)
7.5 India Automation in Biopharmaceutical Industry Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Automation in Biopharmaceutical Industry Sales and Growth Rate (2013-2018)
8 South America Automation in Biopharmaceutical Industry by Countries
8.1 South America Automation in Biopharmaceutical Industry Sales, Revenue and Market Share by Countries
8.1.1 South America Automation in Biopharmaceutical Industry Sales and Market Share by Countries (2013-2018)
8.1.2 South America Automation in Biopharmaceutical Industry Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Automation in Biopharmaceutical Industry Sales and Growth Rate (2013-2018)
8.3 Argentina Automation in Biopharmaceutical Industry Sales and Growth Rate (2013-2018)
8.4 Colombia Automation in Biopharmaceutical Industry Sales and Growth Rate (2013-2018)
9 Middle East and Africa Automation in Biopharmaceutical Industry by Countries
9.1 Middle East and Africa Automation in Biopharmaceutical Industry Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Automation in Biopharmaceutical Industry Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Automation in Biopharmaceutical Industry Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Automation in Biopharmaceutical Industry Sales and Growth Rate (2013-2018)
9.3 UAE Automation in Biopharmaceutical Industry Sales and Growth Rate (2013-2018)
9.4 Egypt Automation in Biopharmaceutical Industry Sales and Growth Rate (2013-2018)
9.5 Nigeria Automation in Biopharmaceutical Industry Sales and Growth Rate (2013-2018)
9.6 South Africa Automation in Biopharmaceutical Industry Sales and Growth Rate (2013-2018)
10 Global Automation in Biopharmaceutical Industry Market Segment by Type
10.1 Global Automation in Biopharmaceutical Industry Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Automation in Biopharmaceutical Industry Sales and Market Share by Type (2013-2018)
10.1.2 Global Automation in Biopharmaceutical Industry Revenue and Market Share by Type (2013-2018)
10.2 Clinical stage automation Sales Growth and Price
10.2.1 Global Clinical stage automation Sales Growth (2013-2018)
10.2.2 Global Clinical stage automation Price (2013-2018)
10.3 Drug discovery stage automation Sales Growth and Price
10.3.1 Global Drug discovery stage automation Sales Growth (2013-2018)
10.3.2 Global Drug discovery stage automation Price (2013-2018)
11 Global Automation in Biopharmaceutical Industry Market Segment by Application
11.1 Global Automation in Biopharmaceutical Industry Sales Market Share by Application (2013-2018)
11.2 Research and Development Sales Growth (2013-2018)
11.3 Clinical Sales Growth (2013-2018)
12 Automation in Biopharmaceutical Industry Market Forecast (2018-2023)
12.1 Global Automation in Biopharmaceutical Industry Sales, Revenue and Growth Rate (2018-2023)
12.2 Automation in Biopharmaceutical Industry Market Forecast by Regions (2018-2023)
12.2.1 North America Automation in Biopharmaceutical Industry Market Forecast (2018-2023)
12.2.2 Europe Automation in Biopharmaceutical Industry Market Forecast (2018-2023)
12.2.3 Asia-Pacific Automation in Biopharmaceutical Industry Market Forecast (2018-2023)
12.2.4 South America Automation in Biopharmaceutical Industry Market Forecast (2018-2023)
12.2.5 Middle East and Africa Automation in Biopharmaceutical Industry Market Forecast (2018-2023)
12.3 Automation in Biopharmaceutical Industry Market Forecast by Type (2018-2023)
12.3.1 Global Automation in Biopharmaceutical Industry Sales Forecast by Type (2018-2023)
12.3.2 Global Automation in Biopharmaceutical Industry Market Share Forecast by Type (2018-2023)
12.4 Automation in Biopharmaceutical Industry Market Forecast by Application (2018-2023)
12.4.1 Global Automation in Biopharmaceutical Industry Sales Forecast by Application (2018-2023)
12.4.2 Global Automation in Biopharmaceutical Industry Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Automation in Biopharmaceutical Industry Picture
Table Product Specifications of Automation in Biopharmaceutical Industry
Figure Global Sales Market Share of Automat
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
